The price of impending death : evidence from compensation awarded to victims contaminated by AIDS in France

An explanation of the estimated amounts of compensation in the case of impending death, using the damages awarded to the contaminated victims as the dependant variable in a single equation regression model which is founded on Lancaster's goods characteristics model and on a model of inter-temporal choice of consumption is presented. The data source of the Compensation Fund for People infected by blood transfusions and the haemophiliacs (FITH) was used to provide the variables deployed. The results indicate the negative effect of age, sex, nationality and medical state, and the positive effect of professional status and the presence of contaminated nearest relatives. One observation is that individuals who suffer from economic damage go more often to the courts than other individuals. Since the objective of the FITH is to award a compensation and to minimize the number of victims who uses the right of appeal against it, the FITH awards a higher compensation in order to dissuade them from going to courts. [Author]]]></dc:description>
   <dc:subject>Value of Life ;  Acquired Immunodeficiency Syndrome ;  Compensation and Redress</dc:subject>
   <dc:language>eng</dc:language>
</oai_dc:dc>
  </metadata>
</record>
<record xmlns="http://www.openarchives.org/OAI/2.0/">
  <header>
    <identifier>oai:serval.unil.ch:BIB_8707</identifier>
    <datestamp>2019-03-09T02:19:10Z</datestamp>
  </header>
  <metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:identifier>https://serval.unil.ch/notice/serval:BIB_8707</dc:identifier>
   <dc:title>Suisse-Tiers Monde. Des réseaux d'expansion aux formes de domination</dc:title>
   <dc:creator>Etemad, B.</dc:creator>
   <dc:type>info:eu-repo/semantics/book</dc:type>
   <dc:type>book</dc:type>
   <dc:date>1998</dc:date>
   <dc:language>fre</dc:language>
</oai_dc:dc>
  </metadata>
</record>
<record xmlns="http://www.openarchives.org/OAI/2.0/">
  <header>
    <identifier>oai:serval.unil.ch:BIB_8707C137D116</identifier>
    <datestamp>2019-03-09T02:19:10Z</datestamp>
  </header>
  <metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:identifier>https://serval.unil.ch/notice/serval:BIB_8707C137D116</dc:identifier>
   <dc:title>Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).</dc:title>
   <dc:identifier>info:doi:10.1002/jmri.21337</dc:identifier>
   <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1002/jmri.21337</dc:relation>
   <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/18425827</dc:relation>
   <dc:creator>Korosoglou, G.</dc:creator>
   <dc:creator>Tang, L.</dc:creator>
   <dc:creator>Kedziorek, D.</dc:creator>
   <dc:creator>Cosby, K.</dc:creator>
   <dc:creator>Gilson, W.D.</dc:creator>
   <dc:creator>Vonken, E.J.</dc:creator>
   <dc:creator>Schär, M.</dc:creator>
   <dc:creator>Sosnovik, D.</dc:creator>
   <dc:creator>Kraitchman, D.L.</dc:creator>
   <dc:creator>Weiss, R.G.</dc:creator>
   <dc:creator>Weissleder, R.</dc:creator>
   <dc:creator>Stuber, M.</dc:creator>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>article</dc:type>
   <dc:date>2008</dc:date>
   <dc:source>Journal of Magnetic Resonance Imaging, vol. 27, no. 5, pp. 1175-1180</dc:source>
   <dc:relation>info:eu-repo/semantics/altIdentifier/pissn/1053-1807[print], 1053-1807[linking]</dc:relation>
   <dc:description><![CDATA[PURPOSE: To investigate the utility of inversion recovery with ON-resonant water suppression (IRON) to create positive signal in normal lymph nodes after injection of superparamagnetic nanoparticles. MATERIALS AND METHODS: Experiments were conducted on six rabbits, which received a single bolus injection of 80 mumol Fe/kg monocrystalline iron oxide nanoparticle (MION-47). Magnetic resonance imaging (MRI) was performed at baseline, 1 day, and 3 days after MION-47 injection using conventional T(1)- and T(2)*-weighted sequences and IRON. Contrast-to-noise ratios (CNR) were measured in blood and in paraaortic lymph nodes. RESULTS: On T(2)*-weighted images, as expected, signal attenuation was observed in areas of paraaortic lymph nodes after MION-47 injection. However, using IRON the paraaortic lymph nodes exhibited very high contrast enhancement, which remained 3 days after injection. CNR with IRON was 2.2 +/- 0.8 at baseline, increased markedly 1 day after injection (23.5 +/- 5.4, P &lt; 0.01 vs. baseline), and remained high after 3 days (21.8 +/- 5.7, *P &lt; 0.01 vs. baseline). CNR was also high in blood 1 day after injection (42.7 +/- 7.2 vs. 1.8 +/- 0.7 at baseline, P &lt; 0.01) but approached baseline after 3 days (1.9 +/- 1.4, P = NS vs. baseline). CONCLUSION: IRON in conjunction with superparamagnetic nanoparticles can be used to perform 'positive contrast' MR-lymphography, particularly 3 days after injection of the contrast agent, when signal is no longer visible within blood vessels. The proposed method may have potential as an adjunct for nodal staging in cancer screening